AMENDMENTS TO EMPLOYMENT AGREEMENTS
Contract Categories:
Human Resources
- Employment Agreements
EX-10.2 3 a5466934ex10-2.htm EXHIBIT 10.2 a5466934ex10-2.htm
Exhibit 10.2
AMENDMENTS TO EMPLOYMENT AGREEMENTS
ARIAD Pharmaceuticals, Inc. (the “Company”) entered into an amendment to the employment agreement between the Company and each of the following executive officers, in April or May 2007, to extend the term of employment thereunder as follows:
Term of Agreement Extended | |||
Name and Title | From | To | |
(December 31 of each year) | |||
Harvey J. Berger, M.D. Chairman and Chief Executive Officer | 2009 | 2011 | |
Laurie A. Allen, Esq. Senior Vice President, Legal and Business Development,Chief Legal Officer and Secretary | 2008 | 2010 | |
David L. Berstein, Esq. Senior Vice President, Chief Patent Counsel | 2008 | 2010 | |
Timothy P. Clackson, Ph.D. Senior Vice President, Chief Scientific Officer | 2008 | 2010 | |
Edward M. Fitzgerald Senior Vice President, Finance and Corporate Operations,Chief Financial Officer and Treasurer | 2008 | 2010 | |
John D. Iuliucci, Ph.D. Senior Vice President, Chief Development Officer | 2008 | 2010 | |
Richard W. Pascoe Senior Vice President, Chief Commercial Officer | 2007 | 2010 |
The term of employment for each officer is thereafter subject to automatic renewal for successive one-year terms (three-year terms in the case of Dr. Berger) absent notice to the contrary by either party.